Search results
Results from the WOW.Com Content Network
Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. [1] They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS. [1] [2] In these situations they decrease the need for blood transfusions. [2]
Erythropoietin (/ ɪ ˌ r ɪ θ r oʊ ˈ p ɔɪ. ɪ t ɪ n,-r ə-,-p ɔɪ ˈ ɛ t ɪ n,-ˈ iː t ɪ n /; [1] [2] [3] EPO), also known as erythropoetin, haematopoietin, or haemopoietin, is a glycoprotein cytokine secreted mainly by the kidneys in response to cellular hypoxia; it stimulates red blood cell production (erythropoiesis) in the bone marrow.
Autologous blood therapy, also known as autologous blood injection or autohemotherapy, comprises certain types of hemotherapy using a person's own blood (auto-+ hemo-+ therapy). There are several kinds, the original belonging only to traditional medicine , alternative medicine , and some newer kind of medicine under investigation.
Platelet-rich plasma (PRP), also known as autologous conditioned plasma, is a concentrate of plasma protein derived from whole blood, centrifuged to remove red blood cells but retaining platelets.
Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. [19] Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause. [19] It may also be used to increase white blood cells for gathering during leukapheresis. [19]
As the U.S. population continues to age, the prevalence of arthritis is expected to increase as well. When we think of arthritis, we often think of worn-down joint tissue that happens as we get older.
High blood pressure, also known as hypertension, is a common health issue, affecting nearly half of adults in the United States (48%).. When an individual is diagnosed with high blood pressure ...
A typical adult patient can safely receive 600 mg of iron sucrose per week, administered in separate doses of 200–300 mg. Most patients experience an increase in their hemoglobin levels of at least 20 g/L. [ 3 ] Administration usually takes from fifteen to thirty minutes [ 3 ] and is done by a medical professional.